MGRC Therapeutics Partners with IMU University to Launch Graduate Trainee Programme

Empowering the Next Generation of Genomics and Biopharmaceutical Professionals  

PETALING JAYA, 31 JULY 2024 – Malaysian Genomics Resource Centre Berhad (“MGRC” or “the Group”), a leading genomics and biopharmaceutical specialist, via MGRC Therapeutics Sdn. Bhd. (“MGRC Therapeutics”), a wholly-owned subsidiary of the Group, is pleased to collaborate with the IMU University, a premier private higher education institution, on its Graduate Trainee Programme. This initiative focuses on fostering industry education excellence and training the next generation of healthcare professionals.

IMU University, renowned for its commitment to producing excellent practitioners, sees this collaboration as a vital step in ensuring their graduates are well-prepared for the competitive job market. With over 30 years of dedicated focus in healthcare education, IMU University holds the distinction of being the initial private medical university to attain self-accreditation status from the Malaysian Qualifications Agency (MQA) and has received SETARA’s highest accolade for the third consecutive time.

The Graduate Trainee Programme offers IMU graduates from the Bachelor of Applied Science (Hons) in Medical Biotechnology and Bachelor of Science (Hons) in Biomedical Science an opportunity to gain hands-on experience in the genomics and biopharmaceutical industry. Selected graduates will benefit from a holistic career pathway leveraging MGRC’s extensive ecosystem. This programme demonstrates the synergy between academia and industry, ensuring curriculum relevancy and early talent development.

The participants will receive mentorship from industry experts, exposure to cutting-edge technologies, and involvement in groundbreaking research projects. The programme is designed to cultivate essential skills such as critical thinking, problem-solving, and innovative thinking, preparing graduates for leadership roles in their future careers. It serves as a training ground for students, offering a smooth transition to the workforce with the possibility of full employment based on performance.

Azri Azerai, Executive Chairman of Malaysian Genomics highlighted the significance of this initiative, stating, “This collaboration with IMU University reflects our dedication to nurturing young talent and supporting the development of future leaders in the genomics and biopharmaceutical sectors. By providing practical training and career opportunities, we are not only contributing to the personal and professional growth of these graduates but also reinforcing our commitment to sustainable and responsible business practices.”

Professor Gerard George, Group Managing Director of IMU University added on the partnership, saying, “We are delighted to collaborate with MGRC on this Graduate Trainee Programme. This initiative is a testament to our ongoing commitment to providing our students with the best possible start to their careers. By partnering with a leading industry player like MGRC, we can ensure that our graduates are equipped with the practical skills and industry knowledge necessary to excel in the rapidly evolving fields of genomics and biopharmaceuticals.”

This collaboration underscores MGRC’s commitment to social responsibility and governance. By investing in education and professional training, MGRC aims to enhance workforce competency, develop a skilled workforce capable of driving future innovations in genomics and biopharmaceuticals, and promote sustainable development. Additionally, it strengthens community engagement by building strong relationships with academic institutions and the community to support educational and professional growth.

This initiative represents MGRC’s proactive approach to integrating ESG principles into its core operations, ensuring that the Group not only achieves business success but also contributes positively to society.